title: ApoE(-/-) mice develop atherosclerosis in the absence of complement component C5.
abstract: Previous studies have suggested that the terminal complex of complement may contribute to the pathogenesis of atherosclerosis. C5b-9 complexes colocalize with the extracellular lipid in the aortic intima of hypercholesterolemic rabbits, and C6-deficient rabbits develop less atherosclerosis than controls. To test the role of complement in atherosclerosis in a different animal model, C5 deficient (C5def) mice were cross-bred with atherosclerosis susceptible apoE(-/-) mice, generating mice deficient in both apoE and C5 and control apoE(-/-) mice. Progeny were typed for C5 titer and serum cholesterol levels. Both male and female mice were fed a high fat diet from weaning until 22 weeks of age. At that time there were no significant differences in plasma cholesterol or triglycerides between apoE(-/-) control and apoE(-/-)/C5def groups. Morphometric analysis of the aortic root lesions gave mean (+/-SEM) lesion areas for male apoE(-/-) and apoE(-/-)/C5def mice of 468,176 +/- 21,982 and 375,182 +/- 53,089 microm(2), respectively (n = 10 each, P value = 0.123). In female apoE(-/-) mice (n = 5), the mean lesion area was 591,981 +/- 53,242 microm(2), compared to 618,578 +/- 83,457 microm(2) for female apoE(-/-)/C5def mice (n = 10) (P value = 0.835). Thus neither male nor female mice showed a significant change in lesion area when C5 was not present. In contrast to the case in the hypercholesterolemic rabbit, activation of the terminal complex of complement does not play a major role in the development of atherosclerosis in apoE(-/-) mice.
authors.affiliation: Merck Research Laboratories, 126 East Lincoln Avenue, RY80W-120, Rahway, NJ 07065, USA.
authors.forename: S
authors.initials: S
authors.lastname: Patel
authors.forename: E M
authors.initials: EM
authors.lastname: Thelander
authors.forename: M
authors.initials: M
authors.lastname: Hernandez
authors.forename: J
authors.initials: J
authors.lastname: Montenegro
authors.forename: H
authors.initials: H
authors.lastname: Hassing
authors.forename: C
authors.initials: C
authors.lastname: Burton
authors.forename: S
authors.initials: S
authors.lastname: Mundt
authors.forename: A
authors.initials: A
authors.lastname: Hermanowski-Vosatka
authors.forename: S D
authors.initials: SD
authors.lastname: Wright
authors.forename: Y S
authors.initials: YS
authors.lastname: Chao
authors.forename: P A
authors.initials: PA
authors.lastname: Detmers
mesh_terms: D000818:Animals; D001011:Aorta / Q000473:pathology; D001057:Apolipoproteins E / Q000235:genetics / Q000502:physiology*; D001161:Arteriosclerosis / Q000235:genetics*; D002784:Cholesterol / Q000097:blood; D003182:Complement C5 / Q000502:physiology*; D005260:Female; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D014280:Triglycerides / Q000097:blood
chemical_list: D001057:Apolipoproteins E; D003182:Complement C5; D014280:Triglycerides; D002784:Cholesterol